NCT05100043View on ClinicalTrials.gov

Interleukin 4 and Interferon Gamma Predictors of Human Papillomavirus Immunotherapy in Warts

CompletedOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

January 3, 2020

Primary Completion Date

July 3, 2020

Study Completion Date

March 2, 2021

Conditions
Warts HandWart, Genital
Interventions
BIOLOGICAL

IL-4 and IFN-γ measurements

Blood samples are withdrawn from participants and whole blood cultures are prepared and stimulated by bivalent HPV vaccine.IL-4 and IFN-γ are measured in culture supernatants

Trial Locations (1)

44519

Zagazig University Faculty of Medicine, Zagazig

All Listed Sponsors
lead

Zagazig University

OTHER_GOV

NCT05100043 - Interleukin 4 and Interferon Gamma Predictors of Human Papillomavirus Immunotherapy in Warts | Biotech Hunter | Biotech Hunter